Jump to Main Content

COVID-19 Resources

(Updated September 25, 2020)

The United States and countries around the world face a major public health concern with the current outbreak of the novel (new) coronavirus (COVID-19). In an effort to serve its members, ASH is maintaining this webpage as a medium to exchange information to assist hematologists in navigating the COVID-19 public health crisis.

While ASH aims to provide a forum for the exchange of information that is helpful, accurate and up-to-date, the relevant health information and data concerning the disease, as well as the various governmental actions and responses to the disease, are changing constantly, and ASH makes no representation, warranty, or guaranty whatsoever as to any information that may be exchanged through this webpage.

It remains the responsibility of each medical professional to decide on the appropriate medical advice, diagnosis, and treatment for patients. In rendering such advice, please bear in mind that although ASH attempts to include on this page information from reliable sources, it has not conducted a substantive review of each item posted below, nor does it have access to sufficient information to police potential conflicts of interest. Particularly given the exigencies presented by the current COVID-19 pandemic, we urge you to assist us identifying information that has been particularly helpful to you so that we might more prominently feature it, as well as any information that is inaccurate, outdated or inappropriate so that we can remove it.


President's Message:

As the world grapples with the novel coronavirus, ASH believes that we can help each other be as knowledgeable and prepared as possible. The information and links below will get us started but please let us know how ASH can help you, your center and your patients. The website will be updated frequently and new features added as needed.

-- ASH President Stephanie J. Lee, MD, MPH 


Featured Resources


Resources for Clinicians

Academic Centers, Hospitals, and Community Practices

Frequently Asked Clinical Questions

Treatments and Prevention

Malignant Topics

Non-malignant Topics

Clinical Laboratory Topics

Clinical FAQ Resources from Other Societies

COVID-19 Treatments

Guidance About COVID-19 Treatment

Clinical Trials and Studies

COVID-19 Registries for Hematologic Conditions

  • ASH RC COVID-19 Registry for Hematology
    The ASH Research Collaborative’s (ASH RC) Data Hub is capturing data on people who test positive for COVID-19 and have been or are currently being treated for a hematologic condition. As data are received, near real-time observational data summaries are reported for clinicians on the front line of the COVID-19 pandemic. Clinicians and other health care providers worldwide are invited to enter de-identified data on all confirmed COVID-19 cases for hematology patients, regardless of recovery or active treatment status. Online data entry takes approximately 5 minutes to complete.
  • Secure-SCD Registry (Medical College of Wisconsin)
    This registry is designed to capture pediatric and adult COVID-19 cases that are occurring across the world in patients living with sickle cell disease.
  • CCC19 (COVID-19 and Cancer Consortium)
    A consortium of over 100 cancer centers and other organizations who have come together to collect data about cancer patients who have been infected with COVID-19.

Restarting Routine Clinical Practice

Additional Resources

American Society of Hematology

HHS (Department of Health and Human Services)

COVID-19: General Resources

Institute for Health Metrics and Evaluation

Johns Hopkins COVID tracker

AMA (American Medical Association)

CDC (Centers for Disease Control and Prevention)

AHRQ (Agency for Healthcare Research and Quality)

WHO (World Health Organization)

Subspecialty Societies

AABB (American Association of Blood Banks)

ACP (American College of Physicians)

ASCO (American Society of Clinical Oncology)  

ASTCT (American Society for Transplantation and Cellular Therapy)

EBMT (European Society for Blood Marrow Transplantation)

EHA (European Hematology Association)

IDSA (Infectious Diseases Society of America)

ISTH (International Society of Thrombosis and Hemostasis)

NCCN (National Comprehensive Care Network)

Journals

New England Journal of Medicine

JAMA (Journal of the American Medical Association)

The Lancet

Journal of Thrombosis and Haemostasis

UpToDate

British Journal of Haematology

Additional Resources

Resources for Researchers

American Society of Hematology

FDA (Food and Drug Administration)

NIH (National Institutes of Health)

Other Resources

  • LitCovid: a curated literature hub by NLM
    This hub tracks up-to-date scientific information about COVID-19. Articles are updated daily and are categorized by different research topics and geographic locations.
  • Memorial Sloan Kettering Seminar Series
    This twice-weekly scientific seminar series featuring illuminating lectures by today’s leaders in basic and translational biomedical science. Seminars are viewable via livestream every Monday and Wednesday at 4:30 pm.
  • Blood and Bone Seminar 
    Dr. Kellie Machlus from Harvard Medical School and Brigham and Women’s Hospital has organized this seminar series to continue scientific education during this time of travel restrictions and meeting cancellations.
  • Connecting the Scientific Community Seminar Series 
    Drs. Kornelia Polyak and David Weinstock from Dana-Farber/Harvard Cancer Center have organized this seminar series (12:00 pm Eastern every Tuesday and Thursday) to facilitate scientific exchanges during the COVID-19 restrictions.

Resources for Trainees

Frequently Asked Questions


Is there a hematology-related COVID-19 resource that has been helpful to you that is not listed here? Is there content here that's inappropriate or outdated? Are there additional topics you would like to see addressed on this site? We welcome your feedback below.

Get Updates

Sign up for email updates to stay abreast of the latest COVID-19 resources recommended by the American Society of Hematology.